Autopsy files of 180 patients were reviewed, who died after BMT between July 1987 and June 1998 and 58 (32.2%) cases, who had experienced intracranial hemorrhage (ICH) were selected. Age, sex, underlying disease, preparatory regimens, immunoprophylaxis, chronic and acute GVHD, survival of the patients and localization and size of hemorrhages were evaluated. There were 33 males and 25 females, with a mean age of 23.4 years. The main underlying disorders for which BMT was performed included SAA (n = 21), CML (n = 13) and AML (n = 10). Forty patients were found to have intraparenchymal hemorrhage, 35 had subarachnoid hemorrhage and eight patients had subdural hemorrhage. In 16 cases the CNS hemorrhage was so extensive that it was considered to be the main cause of death. There was no significant statistical difference concerning sex (P = 0.217), age (P = 0.296), underlying disease (P = 0.352), preparatory regimens (P = 0.07), immunoprophylaxis (P = 0.914), chronic and acute graft-versus-host disease (P = 0.107 and P = 0.631, respectively) and survival (P = 0.701) when comparing patients with or without ICH. However, the number of cases in which the CNS was defined as the main cause of death was higher among patients with ICH than in patients without ICH (n = 16 vs 15) (P = 0.011). We conclude that ICH is common and has a significant mortality rate following BMT. Bone Marrow Transplantation (2002) 29, 29-32. DOI: 10.1038/sj/bmt/1703315 Keywords: bone marrow transplantation; central nervous system; cerebrovascular diseases; hemorrhage Bone marrow transplantation (BMT) has significantly contributed to the therapy of life-threatening hematological and non-hematological disorders. However, the central nervous
system (CNS) can be severely affected by side-effects due to previous treatment, preparatory regimens and immunosuppression. [1] [2] [3] [4] [5] Few published studies have addressed the main findings in the CNS and these have found differences between the incidence of neurological and neuropathological complications following BMT. [3] [4] [5] [6] [7] Furthermore, few autopsy-based studies have been reported to date. 2, 4 It is important to emphasize that autopsy studies seem to induce low levels of demographic bias so that observations based on autopsy series might contribute to clinical and etiopathogenic conclusions. 8, 9 This report examines the autopsy findings in 58 patients who died after BMT and in whom intracranial hemorrhage was a contributory or main cause of death.
Materials and methods
The autopsy files of 180 patients who died after BMT between July 1987 and June 1998 were reviewed. Fiftyeight cases with intracranial hemorrhage unrelated to CNS infection were defined as the study group while the other 122 were included in the control group. Preparatory regimens used in our BMT unit and compared in this study were: (1) cyclophosphamide, (2) cyclophosphamide plus total body irradiation, (3) busulphan plus cyclophosphamide, (4) cyclophosphamide plus anti-thymocyte globulin and (5) others. The immunoprophylaxis regimens used in our BMT unit and compared in our study were: (1) methotrexate, (2) methotrexate plus cyclosporine, (3) cyclosporine plus corticosteroids, (4) methotrexate plus cyclosporine plus corticosteroids and (5) corticosteroids. Platelets were transfused when the platelet count fell below 20 × 10 3 /l, and coagulation tests were performed on a weekly basis, in an attempt to detect and correct coagulation disorders appropriately. During the autopsy studies, brains were removed and fixed for at least 3 weeks in 30% buffered formaldehyde solution. They were cut into several 1-cm thick coronal sections and systematically sampled in 12 different anatomic areas including frontal, parietal, temporal and occipital lobes, insula, thalamus, hypothalamus, mammilary bodies, midbrain, pons, medulla oblongata and cerebellum. Areas containing macroscopic lesions different from those previously mentioned were also sampled. Tissue sections were prepared by routine histological techniques including hematoxylin-eosin and Luxol fast blue/Nissl for myelin analysis. Silver impregnation for axon analysis and stains for micro-organism detection such as periodic acid of Schiff, Ziehl-Nielsen and Grocott's silver impregnation, were performed whenever necessary. Age, sex, underlying disease, preparatory regimens, immunoprophylaxis, chronic and acute graft-versus-host disease and survival of the patients were analyzed. Localization and size of hemorrhages, and their contribution to death, were also evaluated. Statistical analysis was performed comparing the group of patients with intracranial hemorrhage (study group) and without (control group). Chi-square test, Student's t-test and log rank test were used for univariate and multivariate statistical analysis, and P Ͻ 0.05 was defined as statistically significant.
Results
Between July 1987 and June 1998, 845 patients underwent allogeneic (90%) or autologous (10%) BMT at our institution. Three hundred and seventy-one patients died and 180 autopsies were performed. Clinical and neuropathological data of these patients are given in a previous report. 6 Among the 180 brains studied, intracranial hemorrhage was found in 58 patients (32.2%) who comprised the study group. There were 33 (56.9%) males and 25 (43.1%) females. There was no statistical difference between the genders when we compared the study group with the control group (P = 0.217) ( Table 1) . Ages ranged between 5 and 54 years in the study group, with a mean of 23.4 years. The mean age in the control group was 23.9 years, and there was no statistical difference (P = 0.296). The underlying disorders for which BMT was performed are presented in Table 2 . We found no differences in the underlying disease between the study and control groups (P = 0.352) and there was no statistical difference between the two groups either when we correlated the preparatory regimens (P = 0.07), or compared the immunoprophylaxis (P = 0.914). Acute graft-versus-host disease was observed in 53 (43.4%) patients in the control group and in 23 (39.7%) patients with ICH (P = 0.631). There were 37 (30.3%) cases of chronic graft-versus-host disease in the control group Table 1 Variables statistically compared between the study and control groups and 11 (19%) cases among the patients with ICH (P = 0.107). Most of the patients died within the first month after BMT (Figure 1 ). The mean survival was 162 days in the control group and 168 days in the patients with ICH (P = 0.704). Hemorrhages ranged in size from petechiae and focal bleeds to massive lesions that distorted the brain. They were classified as intraparenchymal hemorrhage (IPH), subarachnoid hemorrhage (SAH) and subdural hemorrhage (SDH). Thirty-two patients had more than one type of hemorrhage. Forty patients were found to have IPH, 35 had SAH and eight patients had SDH. All three types of hemorrhage had a slight predominance in the left hemisphere, as shown in Figure 2 . In the study group, 16 (27.6%) patients had CNS lesions so extensive that they were considered to be the main cause of death. The clinical data of those patients are listed in Table 3 . In contrast, in only 15 (12.3%) patients of the control group were extensive CNS lesions found to be the main cause of death (P = 0.011).
Discussion
Cerebrovascular complications are the most prevalent finding in patients who have died after BMT and undergone an autopsy. 6 In the present study the authors focused exclusively on a group of patients (n = 58) with acute intracranial hemorrhage (ICH) excluding those patients with old hemorrhages, infarcts, infections and metabolic disorders. The prevalence of ICH in the present report (32.2%) is the highest when compared to other two post-mortem studies reported in the literature (6.4% 10 and 27% 2 ). However, the reported clinical prevalence of ICH in patients with leukemia and neurological complications following BMT varies widely. Graus et al 3 reported an 11% prevalence of ICH in a series of 425 patients while Antonini et al 11 reported only one case in 115. In a large series of 1402 patients at the Johns Hopkins Hospital, 10 2% of patients developed ICH within the 100 days following BMT. IPH, SAH  90  7  m  16  SAA  IPH, SAH  21  8  f  10  FA  IPH, SAH  1  9  f  16  SAA  IPH  21  10  m  21  SAA  IPH  18  11  f  31  MDS  IPH, SAH, SDH  46  12  f  9  FA  IPH, SAH  2  13  m  9  SAA  IPH, SAH  55  14  f  22  CML  IPH, SAH  31  15  f  34  AML  IPH  276  16  m  17  SAA  IPH, SAH  23 f = female; m = male; BMT = bone marrow transplantation; SAA = severe aplastic anemia; CML = chronic myelogenous leukemia; AML = acute myelogenous leukemia; FA = Fanconi's anemia; MDS = myelodysplasia; BD = Black-Diamond syndrome; IPH = intraparenchymal hemorrhage; SAH = subarchnoid hemorrhage; SDH = subdural hemorrhage.
Among the 180 cases studied, 31 (17.2%) had such extensive CNS lesions that they were considered to be the main cause of death. Sixteen (51.6%) of these 31 cases were CNS hemorrhage, and thus 8.8% of patients (16/180) who died after BMT and underwent an autopsy had CNS hemorrhage as the main cause of death. Although Pomeranz et al 12 concluded that ICH is uncommon following BMT, these authors observed a high mortality rate among patients with ICH following BMT.
There are several factors mentioned in the literature that can be associated with ICH. They include a low platelet count or platelet refractoriness, [3] [4] [5] 11, [13] [14] [15] mechanic ventilation, 13, 14 intrathecal chemotherapy, 12, 18 lumbar puncture, 5,18 irradiation 5 and nonbacterial thrombotic endocarditis. 15 The factor most discussed is thrombocytopenia. However, the importance of the platelet count as a risk factor for ICH is controversial. Morhmann et al 4 and Pomeranz et al 12 mentioned that thrombocytopenia and/or coagulopathies alone are often not sufficient to produce cerebral hemorrhage, and induction of capillary endothelial damage by alkylating agents in pretransplant conditioning might be a contributory factor. On the other hand, Oppenheim-Eden et al 14 and Graus et al 3 suggested that thrombocytopenia may play a role in ICH. Mehta et al 13 tried to find factors for early identification of patients at risk of death due to infections, hemorrhage or graft failure after BMT. Although these authors did not specifically discuss ICH, they concluded that low leukocyte count between days 12 and 22 after allogeneic BMT could be highly predictive of poor outcome.
In the present study we compared underlying diseases, preparatory regimens, immunoprophylaxis and occurrence of chronic or acute GVHD in patients with or without ICH, in an attempt to establish a relationship between these variables and the onset of ICH, but we were unable to demonstrate a difference between these factors either on multivariate or on univariate analysis. There was also no significant statistical difference concerning sex, age, underlying disease and survival when comparing the patients with ICH and those without. However, Fanconi anemia was slightly more prevalent among patients with ICH, since these patients are prone to subdural and subarachnoid hemorrhages. 15 A possible reason for this finding is the associated vascular and endothelial fragility, particularly when they are exposed to alkylating agents. 20 However, further studies are needed to confirm these observations.
The hemorrhages within the CNS were randomly distributed and varied enormously in size and severity. Frontal, parietal and occipital lobes were frequently involved. Although the left hemisphere seemed to be more often involved, the significance of this finding is not clear. In the group of patients who died due to ICH, all had IPH as the main cause of death and in none of the cases dying of ICH did the pattern of SAH or SDH appear significant.
We conclude that ICH is common and leads to significant mortality following BMT. Sex, age, underlying disease, preparatory regimen, immunoprophylaxis, chronic and acute graft-versus-host disease and survival were not statistically relevant as predictors of onset or gravity of hemorrhage.
